Logo
Live News iconLive NewsSmart Screener iconSmart ScreenerTrade Opportunities iconTrade Opportunities
Open Account
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account

TOOLS

Live NewsSmart ScreenerTrade Opportunities

StockkASK powered by Indira Securities

Kerala Ayurveda Ltd (KERALAYUR) Share Price, Fundamentals & Technical Analysis

Company Overview

Founded Year

1992

Listed Year

1995

Headquarter

Athani, near Alwaye, Kerala, India

MD/CEO

-

Website

https://www.keralaavurveda.biz

Company Facts

What we do

Kerala Ayurveda Ltd is a leading integrated Ayurvedic healthcare company offering manufacturing, research, clinics, hospitals, wellness resorts, and herbal cultivation.

Founded in

1,992

Market share

Recognized as a frontline manufacturer of specialty patent Ayurvedic medicines with strong domestic presence through 75 franchisees and 400 stockists.

Problem solved

Providing authentic Ayurvedic healthcare products and services to address health and wellness through traditional and modern methods.

Top clients or who we serve

Serves consumers (B2C) and wellness seekers globally including high-income segments, tourists, NRIs, and healthcare clients.

Key management

-

Our journey and innovations

Established in 1992; expanded manufacturing and wellness services; international subsidiaries in USA, Germany, Singapore; launched new medicinal products and biofertilizer initiatives.

Where we operate

India (Kerala and other states), USA, Germany, Singapore, and export presence in multiple countries including UK, Italy, Japan.

Top products or what we offer

Specialty Ayurvedic patent medicines (Tussnil, Liposem, Mathrukalpam), wellness resorts, Ayurvedic clinics, pharmacies, and healthcare software solutions.

Top brands

Tussnil, Liposem, Mathrukalpam - market recognized Ayurvedic products with clinical proof; AyurvedaGram wellness centers; Kerala Ayurveda River Retreat Resort.

Raw materials needed

Medicinal herbs and plant-based raw materials cultivated and sourced by the company.

Raw materials supplier

In-house cultivation and likely vetted herb suppliers (specific names not disclosed).

Recurring vs cyclical contribution

Revenue mainly from recurring sales of medicines and wellness services; some cyclical project-based revenues.

Our industry position

Established leader in Ayurvedic healthcare manufacturing and wellness services with notable international subsidiaries.

Financial highlights

Standalone revenue around Rs. 72.7 crore in FY2024-25; net loss Rs. 13.8 crore; consolidated revenue Rs. 120.3 crore.

Geographical revenue split

Approximately 70% domestic and 30% international revenue.

Order book

-

Whats driving growth

Product innovation, geographic expansion, wellness tourism, and increased global interest in Ayurveda.

Our future plans

Expanding wellness resorts, increasing manufacturing capacity, enhancing global subsidiaries, and improving clinic network.

Our green promise

Focus on herbal cultivation, biofertilizer development, and sustainable Ayurveda practices.

Our people and values

Employs over 600 people, emphasizes talent development, diversity, and ethical workplace policies.

Key challenges ahead

Regulatory compliance, maintaining profitability, market competition, and supply chain sustainability.

Interesting facts

Operates a unique integrated system combining manufacturing, hospitals, resorts, and global subsidiaries.

Risks and strategy

Mitigates risks through R&D, regulatory adherence, expanding global footprint, and diversification across healthcare segments.

Market Footprint

Top Clients

Top Clients

Serves consumers (B2C) and wellness seekers globally including high-income segments, tourists, NRIs, and healthcare clients.

Top Products

Top Products

Specialty Ayurvedic patent medicines (Tussnil, Liposem, Mathrukalpam), wellness resorts, Ayurvedic clinics, pharmacies, and healthcare software solutions.

Price Movement & Share Holding

Today's High/Low

216.1222.95

52 Week High/Low

150625
Past Returns

1 week

-8.21%

1 month

33.99%

3 month

-15.89%

1 year

-35.82%

3 year

114.09%

5 year

305.05%

Share Holding

Promoters

35.61%

FII

0.17%

DII

0.02%

Retail

48.34%

Others

15.86%

Company Overview

Founded Year

1992

Listed Year

1995

Headquarter

Athani, near Alwaye, Kerala, India

MD/CEO

-

Website

https://www.keralaavurveda.biz

Price Movement & Share Holding

Today's High/Low

216.1222.95

52 Week High/Low

150625

Past Returns

1 week

-8.21%

1 month

33.99%

3 month

-15.89%

1 year

-35.82%

3 year

114.09%

5 year

305.05%

Share Holding

Promoters

35.61%

FII

0.17%

DII

0.02%

Retail

48.34%

Others

15.86%

Company Facts

What we do

Kerala Ayurveda Ltd is a leading integrated Ayurvedic healthcare company offering manufacturing, research, clinics, hospitals, wellness resorts, and herbal cultivation.

Founded in

1992

Market share

Recognized as a frontline manufacturer of specialty patent Ayurvedic medicines with strong domestic presence through 75 franchisees and 400 stockists.

Problem solved

Providing authentic Ayurvedic healthcare products and services to address health and wellness through traditional and modern methods.

Top clients or who we serve

Serves consumers (B2C) and wellness seekers globally including high-income segments, tourists, NRIs, and healthcare clients.

Our journey and innovations

Established in 1992; expanded manufacturing and wellness services; international subsidiaries in USA, Germany, Singapore; launched new medicinal products and biofertilizer initiatives.

Where we operate

India (Kerala and other states), USA, Germany, Singapore, and export presence in multiple countries including UK, Italy, Japan.

Top products or what we offer

Specialty Ayurvedic patent medicines (Tussnil, Liposem, Mathrukalpam), wellness resorts, Ayurvedic clinics, pharmacies, and healthcare software solutions.

Top brands

Tussnil, Liposem, Mathrukalpam - market recognized Ayurvedic products with clinical proof; AyurvedaGram wellness centers; Kerala Ayurveda River Retreat Resort.

Raw materials needed

Medicinal herbs and plant-based raw materials cultivated and sourced by the company.

Raw materials supplier

In-house cultivation and likely vetted herb suppliers (specific names not disclosed).

Recurring vs cyclical contribution

Revenue mainly from recurring sales of medicines and wellness services; some cyclical project-based revenues.

Our industry position

Established leader in Ayurvedic healthcare manufacturing and wellness services with notable international subsidiaries.

Financial highlights

Standalone revenue around Rs. 72.7 crore in FY2024-25; net loss Rs. 13.8 crore; consolidated revenue Rs. 120.3 crore.

Geographical revenue split

Approximately 70% domestic and 30% international revenue.

Whats driving growth

Product innovation, geographic expansion, wellness tourism, and increased global interest in Ayurveda.

Our future plans

Expanding wellness resorts, increasing manufacturing capacity, enhancing global subsidiaries, and improving clinic network.

Our green promise

Focus on herbal cultivation, biofertilizer development, and sustainable Ayurveda practices.

Our people and values

Employs over 600 people, emphasizes talent development, diversity, and ethical workplace policies.

Key challenges ahead

Regulatory compliance, maintaining profitability, market competition, and supply chain sustainability.

Interesting facts

Operates a unique integrated system combining manufacturing, hospitals, resorts, and global subsidiaries.

Risks and strategy

Mitigates risks through R&D, regulatory adherence, expanding global footprint, and diversification across healthcare segments.

Market Footprint

Top Clients

Top Clients

Serves consumers (B2C) and wellness seekers globally including high-income segments, tourists, NRIs, and healthcare clients.

Top Products

Top Products

Specialty Ayurvedic patent medicines (Tussnil, Liposem, Mathrukalpam), wellness resorts, Ayurvedic clinics, pharmacies, and healthcare software solutions.

StockkASK gives smart, data-driven insights to support your analysis. Review independently and invest responsibly.